One of the advantages of pursuing a diversified approach, not only to vaccine procurement but PPE procurement also, was that we built up Canada's supply chains, and now 40% of our PPE contracts by dollar value are with Canadian manufacturers. In other words, we do have the capacity to be a global leader in the sharing of PPE and eventually vaccines, when we do have more vaccines in this country, and they are continuing to come in by the millions.
Through our leadership in the WTO and the the Ottawa Group, we're going to continue to be a strong advocate for equitable access.